NeoGenomics Inc (NEO)
13.85
-0.18
(-1.28%)
USD |
NASDAQ |
Apr 25, 16:00
14.01
+0.16
(+1.16%)
After-Hours: 20:00
NeoGenomics Cash from Investing (TTM): 76.71M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.71M |
| September 30, 2023 | 58.45M |
| June 30, 2023 | 33.43M |
| March 31, 2023 | 12.21M |
| December 31, 2022 | 0.517M |
| September 30, 2022 | -8.003M |
| June 30, 2022 | -18.49M |
| March 31, 2022 | -465.63M |
| December 31, 2021 | -632.37M |
| September 30, 2021 | -651.64M |
| June 30, 2021 | -707.67M |
| March 31, 2021 | -272.42M |
| December 31, 2020 | -159.44M |
| September 30, 2020 | -136.66M |
| June 30, 2020 | -73.26M |
| March 31, 2020 | -58.14M |
| December 31, 2019 | -19.63M |
| September 30, 2019 | -142.15M |
| June 30, 2019 | -136.98M |
| March 31, 2019 | -138.22M |
| December 31, 2018 | -139.69M |
| September 30, 2018 | -14.61M |
| June 30, 2018 | -14.77M |
| March 31, 2018 | -15.35M |
| December 31, 2017 | -13.69M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.34M |
| June 30, 2017 | -10.94M |
| March 31, 2017 | -8.507M |
| December 31, 2016 | -6.501M |
| September 30, 2016 | -78.80M |
| June 30, 2016 | -77.40M |
| March 31, 2016 | -75.31M |
| December 31, 2015 | -75.16M |
| September 30, 2015 | -2.736M |
| June 30, 2015 | -8.816M |
| March 31, 2015 | -9.561M |
| December 31, 2014 | -9.602M |
| September 30, 2014 | -9.073M |
| June 30, 2014 | -3.369M |
| March 31, 2014 | -2.655M |
| December 31, 2013 | -2.011M |
| September 30, 2013 | -1.838M |
| June 30, 2013 | -2.21M |
| March 31, 2013 | -2.577M |
| December 31, 2012 | -3.652M |
| September 30, 2012 | -3.859M |
| June 30, 2012 | -2.822M |
| March 31, 2012 | -2.14M |
| December 31, 2011 | -0.897M |
| September 30, 2011 | -0.441M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-707.67M
Minimum
Jun 2021
76.71M
Maximum
Dec 2023
-173.75M
Average
-73.26M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
| Teladoc Health Inc | -156.35M |
| Abbott Laboratories | -3.133B |
| Halozyme Therapeutics Inc | -96.91M |
| Verastem Inc | -44.45M |
| Ocugen Inc | 3.077M |